Companies that offer high-deductible health plans (HDHPs) are seeing significant dissatisfaction from employees when it comes to drug utilization management, a new report has found. The report also ...

AUSTIN, Texas--(BUSINESS WIRE)--Prodigy Care Services, a leader in innovative pharmacy solutions, today announced the launch of Specialty Nexus, a groundbreaking specialty drug management solution ...

A bipartisan bill introduced in the Ohio House aims to reimburse state employees and elected officials for out-of-pocket costs related to GLP-1 drugs used for chronic ...

SaveHealth reports that Zepbound and Wegovy, both FDA-approved weight loss injectables, differ in mechanisms and efficacy.

Given the increased use — and misuse — of opioid medications, it is imperative that we continue to expand access to drug-free pain treatment options that can effectively address the underlying cause ...

Although the literature has investigated utilization management practices, how they align with clinical practice guidelines is not well understood. 10, 11 A better understanding of this alignment ...

Discretionary manufacturer discounts for Orphan Drug therapies can help health systems achieve more across multiple sites of care. The McKesson Orphan Drug Support Program is the industry leader in ...

What are the Pain Management Drugs? Pain management drugs are defined broadly as any medication that relieves pain. Many different pain medicines exist, and each one has benefits and disadvantages.

An announcement from CSPC Pharmaceutical Group ( ($HK:1093) ) is now available. CSPC Pharmaceutical Group announced that its new drug application ...

A medication used to manage type 2 diabetes is now being used off-label as a weight loss drug.It's called "Ozempic" or "Wegovy."You're probably seeing it more often. But there are lots of questions ...

AstraZeneca said work on its new plant north of Charlottesville will begin immediately and be open within five years.

Aspen Pharmacare said it had secured regulatory approval to market Eli Lilly's blockbuster diabetes and obesity drug, ...